Free Trial

The Pennant Group (PNTG) Stock Price, News & Analysis

The Pennant Group logo
$25.42 +0.62 (+2.50%)
Closing price 04:00 PM Eastern
Extended Trading
$25.42 0.00 (0.00%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About The Pennant Group Stock (NASDAQ:PNTG)

Key Stats

Today's Range
$24.40
$25.51
50-Day Range
$22.21
$28.35
52-Week Range
$19.37
$37.13
Volume
174,150 shs
Average Volume
215,008 shs
Market Capitalization
$875.21 million
P/E Ratio
37.38
Dividend Yield
N/A
Price Target
$34.80
Consensus Rating
Moderate Buy

Company Overview

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

Remove Ads

The Pennant Group Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
75th Percentile Overall Score

PNTG MarketRank™: 

The Pennant Group scored higher than 75% of companies evaluated by MarketBeat, and ranked 222nd out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    The Pennant Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    The Pennant Group has only been the subject of 2 research reports in the past 90 days.

  • Read more about The Pennant Group's stock forecast and price target.
  • Earnings Growth

    Earnings for The Pennant Group are expected to grow by 17.33% in the coming year, from $0.75 to $0.88 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of The Pennant Group is 37.38, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.84.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of The Pennant Group is 37.38, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 24.59.

  • Price to Earnings Growth Ratio

    The Pennant Group has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    The Pennant Group has a P/B Ratio of 5.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about The Pennant Group's valuation and earnings.
  • Percentage of Shares Shorted

    1.81% of the float of The Pennant Group has been sold short.
  • Short Interest Ratio / Days to Cover

    The Pennant Group has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in The Pennant Group has recently decreased by 1.83%, indicating that investor sentiment is improving.
  • Dividend Yield

    The Pennant Group does not currently pay a dividend.

  • Dividend Growth

    The Pennant Group does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.81% of the float of The Pennant Group has been sold short.
  • Short Interest Ratio / Days to Cover

    The Pennant Group has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in The Pennant Group has recently decreased by 1.83%, indicating that investor sentiment is improving.
  • News Sentiment

    The Pennant Group has a news sentiment score of 1.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.78 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for The Pennant Group this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for PNTG on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, The Pennant Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $18,540.00 in company stock.

  • Percentage Held by Insiders

    Only 5.80% of the stock of The Pennant Group is held by insiders.

  • Percentage Held by Institutions

    85.88% of the stock of The Pennant Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about The Pennant Group's insider trading history.
Receive PNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for The Pennant Group and its competitors with MarketBeat's FREE daily newsletter.

PNTG Stock News Headlines

Wells Fargo Remains a Hold on Pennant Group (PNTG)
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Pennant Group price target lowered to $28 from $32 at Truist
Pennant Group (PNTG) Gets a Hold from Truist Financial
See More Headlines

PNTG Stock Analysis - Frequently Asked Questions

The Pennant Group's stock was trading at $26.52 at the start of the year. Since then, PNTG stock has decreased by 4.1% and is now trading at $25.42.
View the best growth stocks for 2025 here
.

The Pennant Group, Inc. (NASDAQ:PNTG) announced its quarterly earnings results on Wednesday, February, 28th. The company reported $0.18 earnings per share for the quarter, missing the consensus estimate of $0.19 by $0.01. The firm earned $145.95 million during the quarter, compared to analyst estimates of $136.79 million. The Pennant Group had a net margin of 3.24% and a trailing twelve-month return on equity of 13.47%.

Top institutional investors of The Pennant Group include FMR LLC (11.37%), 8 Knots Management LLC (7.08%), Vanguard Group Inc. (6.58%) and Van Berkom & Associates Inc. (6.40%). Insiders that own company stock include John G Nackel, Brent Guerisoli, John J Gochnour, Jennifer Freeman and Joanne Stringfield.
View institutional ownership trends
.

Shares of PNTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that The Pennant Group investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), ServiceNow (NOW), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

Last Earnings
2/28/2024
Today
3/27/2025
Next Earnings (Estimated)
5/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Health services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:PNTG
Fax
N/A
Employees
5,340
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$34.80
High Stock Price Target
$38.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+36.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

Trailing P/E Ratio
37.38
Forward P/E Ratio
33.89
P/E Growth
2.24
Net Income
$13.38 million
Pretax Margin
4.46%

Debt

Sales & Book Value

Annual Sales
$695.24 million
Cash Flow
$0.77 per share
Price / Cash Flow
32.92
Book Value
$4.86 per share
Price / Book
5.23

Miscellaneous

Free Float
32,356,000
Market Cap
$875.21 million
Optionable
Optionable
Beta
2.06
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (NASDAQ:PNTG) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners